Dr Caplan in The Media

📺 Dr. Benjamin Caplan in the Media

Broadcast news segments, investigative healthcare reports, academic features, and national clinical commentary.

NBC Boston
CBS News
FOX 5 DC
Forbes
The Boston Globe
NEJM
Voice of America

Media Profile: Benjamin Caplan, MD is a frequent expert clinical source on television, radio, and national print journalism, providing scientific commentary on medical cannabis, clinical endocannabinology, healthcare legislation, pediatric autism therapy, and senior polypharmacy reduction across major media networks.

Featured Broadcast Reel

Television & Broadcast News

FOX 5 DC

How Marijuana Research Can Benefit Americans

Dr. Benjamin Caplan joins FOX 5 DC to discuss federal clinical research initiatives, cannabinoid efficacy, and evidence-grounded medicine.

Watch Segment on FOX 5 →

CBS News Boston

Severe Autism & Life-Changing Clinical Improvements

CBS News feature highlighting life-changing therapeutic improvements and clinical cannabis oversight for pediatric autism patients.

Watch on CBS News →

NBC Boston (WBTS)

Is It Time for Health Insurers to Cover Medical Marijuana?

Investigative reporting by NBC Boston on healthcare economics, insurance hurdles, and clinical access for chronic symptom management.

Watch on NBC Boston →

Voice of America

International Feature: Cannabis Creation & Cognizance

Global VOA Connect feature exploring Dr. Caplan’s clinical practice and the physiological mechanisms of the endocannabinoid system.

Watch on Voice of America →

7News WHDH

7News Investigation: Swapping Pills for Pot

Investigative report examining how clinician-guided cannabinoid therapies help patients reduce reliance on prescription opioids and polypharmacy.

Watch on 7News →

Boston 25 News (WFXT)

Rising Autism Rates & Emerging Therapeutic Pathways

Dr. Caplan provides clinical perspectives on pediatric neurological health, rising diagnosis rates, and integrative clinical research.

Watch on Boston 25 →

National Press & Clinical Publications

Forbes Health

Clinical Guides: CBD Isolate & Broad-Spectrum Formulations

Expert clinical breakdown by Dr. Caplan on the molecular differences, therapeutic windows, and patient titration protocols for CBD.

Read on Forbes →

The Boston Globe

Clinician-Guided Digital Care: EO Care Launch

The Boston Globe covers the launch of EO Care and Dr. Caplan’s venture to bring clinical decision support to multi-state therapeutic cannabis care.

Read in The Boston Globe →

Physicians Weekly

Safeguarding Physicians & Navigating Modern Healthcare

Dr. Caplan discusses legal frameworks, clinical compliance, and physician safeguards in non-traditional medicine.

Read on Physicians Weekly →

Fatherly Health

All Cannabis Use Can Be Therapeutic: Doctor’s Guide

Dr. Caplan provides evidence-based guidance for parents on safety, stigma, harm reduction, and medical cannabis in family life.

Read on Fatherly →

The New England Journal of Medicine

Medical Marijuana for Chronic Pain (Oct. 18, 2018)

Peer-reviewed Clinical Decisions feature co-authored by Lisa Caulley, Benjamin Caplan, MD, and Edgar Ross (NEJM 379(16):1575–1577; PMID: 30332574).

Read in NEJM →

Forbes (Oct. 8, 2024)

Cannabis Compounds Show ‘Promising Potential As Anti-Cancer Agents’

Dr. Caplan provides clinical perspective on peer-reviewed oncology research examining cannabinoids and cell modulation.

Read on Forbes →

Forbes (Sept. 5, 2024)

Marijuana Users Had Better Covid-19 Outcomes, New Study Shows

Dr. Caplan comments on population-level clinical research and methodology examining cannabis use and COVID-19 outcomes.

Read on Forbes →

Forbes (Dec. 16, 2019)

Vaping Cannabis Flower Is Ideal For Older Adults

Feature quoting Dr. Caplan on safe delivery methods, temperature control, and geriatric clinical cannabis care.

Read on Forbes →

Forbes (Apr. 15, 2019)

New Study Suggests Cannabis May Be Effective For Rheumatoid Arthritis

Dr. Caplan shares clinical observations on cannabinoid therapy for inflammatory joint pain and older patients.

Read on Forbes →

SEC Filing & Trade Press (2020)

Akerna Acquisition of solo* sciences

Public SEC Form 8-K (Jan. 21, 2020) and New Cannabis Ventures coverage of Akerna Corp.’s acquisition of solo* sciences, co-founded by Dr. Caplan.

View SEC Form 8-K →